Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
STOK holding history
Stoke Therapeutics, Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
STOK overviewAll 13F holders of STOKFull Q2 2026 holdings
- Shares (Q2 2026)
- 63,010
- Value
- $2.06M
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 63,010 | $2.06M | <0.1% | +16,512+35.5% | Added | Holders |
| Q1 2026 | 46,498 | $1.51M | <0.1% | −20,004−30.1% | Reduced | Holders |
| Q4 2025 | 66,502 | $2.11M | <0.1% | +21,838+48.9% | Added | Holders |
| Q3 2025 | 44,664 | $1.05M | <0.1% | +15,234+51.8% | Added | Holders |
| Q2 2025 | 29,430 | $334.0K | <0.1% | −10,460−26.2% | Reduced | Holders |
| Q1 2025 | 39,890 | $265.3K | <0.1% | −2,940−6.9% | Reduced | Holders |
| Q4 2024 | 42,830 | $472.4K | <0.1% | +42,830 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −32,647−100.0% | Sold out | Holders |
| Q3 2023 | 32,647 | $128.6K | <0.1% | +165+0.5% | Added | Holders |
| Q2 2023 | 32,482 | $345.3K | <0.1% | +3,397+11.7% | Added | Holders |
| Q1 2023 | 29,085 | $242.3K | <0.1% | +2,336+8.7% | Added | Holders |
| Q4 2022 | 26,749 | $246.9K | <0.1% | +5,234+24.3% | Added | Holders |
| Q3 2022 | 21,515 | $276.0K | <0.1% | −1,730−7.4% | Reduced | Holders |
| Q2 2022 | 23,245 | $307.0K | <0.1% | −15,148−39.5% | Reduced | Holders |
| Q1 2022 | 38,393 | $808.0K | <0.1% | −4,178−9.8% | Reduced | Holders |
| Q4 2021 | 42,571 | $1.02M | <0.1% | −2,463−5.5% | Reduced | Holders |
| Q3 2021 | 45,034 | $1.15M | <0.1% | −3,317−6.9% | Reduced | Holders |
| Q2 2021 | 48,351 | $1.63M | <0.1% | +48,351 | New | Holders |